What is Brigatinib?

Category: Prescription Drugs

Most popular types: Alunbrig

false

Brigatinib is indicated for treatment of anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC).

Dosages

Based on patients currently taking Brigatinib

Dosage Patients
180 mg daily 1

Duration

Currently taking Brigatinib

Duration Patients
1 - 2 years 1
Last updated:
There are no evaluations for Brigatinib.